trending Market Intelligence /marketintelligence/en/news-insights/trending/tqywpfz8eopk8lhtr7z9ba2 content esgSubNav
In This List

Scythian Biosciences adds board member

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Scythian Biosciences adds board member

Scythian Biosciences Corp. appointed Andrew DeFrancesco to its board of directors, effective Sept. 4.

DeFrancesco is chairman of Cool Holdings Inc., a Nasdaq-listed investment company.

Toronto-based Scythian Biosciences develops cannabis-derived treatments for concussions and traumatic brain injuries.